SCHEMBL1315871

SCHEMBL1315871

C=C[Si](Cl)(C=C)CCCCCCCC

nearest known ligand 0.42

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
TSHR P16473 6/20 0.42
THRB P10828 1/20 0.38
ZDHHC20 Q5W0Z9 1/20 0.36
ZDHHC2 Q9UIJ5 1/20 0.36
ALDH1A1 P00352 3/20 0.36
FAAH O00519 1/20 0.34
DNM1 Q05193 5/20 0.31
LMNA P02545 2/20 0.31
MEN1 O00255 2/20 0.31
KMT2A Q03164 2/20 0.31
HSD17B10 Q99714 1/20 0.31
SLC22A1 O15245 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5483351 1.00 TSHR (0.42) TSHRTHRBZDHHC20ZDHHC2ALDH1A1
SCHEMBL1317936 0.90 TSHR (0.38) TSHRZDHHC20ZDHHC2ALDH1A1LMNA
SCHEMBL28796617 0.81 TSHR (0.42) TSHRTHRBZDHHC20ZDHHC2ALDH1A1
SCHEMBL11383136 0.81 TSHR (0.42) TSHRTHRBZDHHC20ZDHHC2ALDH1A1
SCHEMBL812114 0.81 TSHR (0.42) TSHRTHRBZDHHC20ZDHHC2ALDH1A1
SCHEMBL28112915 0.81 TSHR (0.42) TSHRTHRBZDHHC20ZDHHC2ALDH1A1
SCHEMBL1315956 0.81 TSHR (0.42) TSHRTHRBZDHHC20ZDHHC2ALDH1A1
SCHEMBL1315286 0.79
SCHEMBL5484219 0.79 TSHR (0.41) TSHRTHRBZDHHC20ZDHHC2ALDH1A1
SCHEMBL1317866 0.79 TSHR (0.41) TSHRTHRBZDHHC20ZDHHC2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8163950-B2 Processes for the production of tri-organo-monoalkoxysilanes and process for the production of tri-organo-monochlorosilanes SHIN-ETSU CHEMICAL CO., LTD. (JP) 2012-04-24 US disclosed
US-20110275849-A1 PROCESSES FOR THE PRODUCTION OF TRI-ORGANO-MONOALKOXYSILANES AND PROCESS FOR THE PRODUCTION OF TRI-ORGANO-MONOCHLOROSILANES BANNOU TADASHI 2011-11-10 US disclosed
US-8008521-B2 Processes for the production of tri-organo-monoalkoxysilanes and process for the production of tri-organo-monochlorosilanes HOKKO CHEMICAL INDUSTRY CO., LTD. (JP) 2011-08-30 US disclosed
CN-1837221-B Production processes for triorganomonochlorosilanes HOKKO CHEM IND CO 2011-06-08 CN disclosed
US-20090082585-A1 PROCESSES FOR THE PRODUCTION OF TRI-ORGANO-MONOALKOXYSILANES AND PROCESS FOR THE PRODUCTION OF TRI-ORGANO-MONOCHLOROSILANES BANNOU TADASHI 2009-03-26 US disclosed
US-7459577-B2 Reacting a chlorosilane with grignard reagent SHIN-ETSU CHEMICAL CO., LTD. (JP) 2008-12-02 US disclosed
EP-1596193-B1 Novel stationary phases for use in high-performance liquid chromatography AGILENT TECHNOLOGIES INC (US) 2007-06-20 EP disclosed
CN-1296374-C Method for producing triorgano-monoalkoxysilanes and method for producing triorgano-monochlorosilanes HOKKO CHEM IND CO (JP) 2007-01-24 CN disclosed
CN-1837221-A Production processes for triorganomonochlorosilanes HOKKO CHEM IND CO (JP) 2006-09-27 CN disclosed
US-20060076296-A1 Novel stationary phases for use in high-performance liquid chromatography AGILENT TECHNOLOGIES, INC. 2006-04-13 US disclosed
EP-1596193-A1 Novel stationary phases for use in high-performance liquid chromatography Agilent Technologies, Inc. (US) 2005-11-16 EP disclosed
US-20050242038-A1 Novel stationary phases for use in high-performance liquid chromatography AGILENT TECHNOLOGIES, INC. 2005-11-03 US disclosed
CN-1612886-A Method for producing triorgano-monoalkoxysilanes and method for producing triorgano-monochlorosilanes HOKKO CHEM IND CO (JP) 2005-05-04 CN disclosed
US-20050070730-A1 Production processes for triorganomonoalkoxysilanes and triorganomonochlorosilanes SHIN-ETSU CHEMICAL CO., LTD. (JP) 2005-03-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110275849-A1 PROCESSES FOR THE PRODUCTION OF TRI-ORGANO-MONOALKOXYSILANES AND PROCESS FOR THE PRODUCTION OF TRI-ORGANO-MONOCHLOROSILANES MLX, HAX1, RPS4X TSHR 954/4885THRB 731/4885ZDHHC20 3290/4885
US-20090082585-A1 PROCESSES FOR THE PRODUCTION OF TRI-ORGANO-MONOALKOXYSILANES AND PROCESS FOR THE PRODUCTION OF TRI-ORGANO-MONOCHLOROSILANES MLX, HAX1, RPS4X TSHR 954/4885THRB 731/4885ZDHHC20 3290/4885
US-20050070730-A1 Production processes for triorganomonoalkoxysilanes and triorganomonochlorosilanes MLX, HAX1, GRIA3 TSHR 682/4885THRB 628/4885ZDHHC20 3412/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.